Related items
Trial Projects:
- Postoperative Ileus: Duration and Severity Assessment With the SmartPill® (PIDuSA)
- Ranibizumab In Pigment Epithelium Tears Secondary To Age-Related Macular Degeneration Study (RIP)
- Efficacy and Safety Study of Lomustine/Temozolomide Combination Therapy vs. Standard Therapy for Glioblastoma Patients (CeTeG)
- Chromoendoskopie versus konventionelle Endoskopie bei Patienten mit Polyposis-Erkrankungen (ChroPol)
- A multicenter, open label, single-arm pilot study to evaluate the efficacy and safety of guselkumab in patients with moderate to severe palmoplantar pustulosis (PPP)
- Echtzeit-Nutzung von automatisierter Intelligenz (CADEYE) bei der Darmkrebs-Überwachung von Patienten mit Lynch-Syndrom
Institutions: University Hospital Bonn Department of Surgery, University Hospital Bonn Department of Ophthalmology, Default Institution
Postoperative ileus (POI) is a frequent complication after abdominal surgery leading to nausea, vomiting and infectious complications. Bowel dysmotility can last for days and necessitates parenteral nutrition resulting in an prolonged hospital stay and a high economic burden.
Until now there is no evidence based therapy of manifest POI because of missing valid surrogate markers demonstrating the severity and resolution of POI.
A novel tool to examine gastrointestinal function is the SmartPill®. ...
Public web page: https://clinicaltrials.gov/study/NCT02329912
Start date: 1st Dec 2014
End date: 31st Dec 2016
Organisms: Not specified